Prevention strategies of postoperative adhesion in soft tissues by applying biomaterials: Based on the mechanisms of occurrence and development of adhesions
Source abstract
Abstract
Postoperative adhesion (POA) widely occurs in soft tissues and usually leads to chronic pain, dysfunction of adjacent organs and some acute complications, seriously reducing patients' quality of life and even being life-threatening. Except for adhesiolysis, there are few effective methods to release existing adhesion. However, it requires a second operation and inpatient care and usually triggers recurrent adhesion in a great incidence. Hence, preventing POA formation has been regarded as the most effective clinical strategy. Biomaterials have attracted great attention in preventing POA because they can act as both barriers and drug carriers. Nevertheless, even though much reported research has been demonstrated their efficacy on POA inhibition to a certain extent, thoroughly preventing POA formation is still challenging. Meanwhile, most biomaterials for POA prevention were designed based on limited experiences, not a solid theoretical basis, showing blindness. Hence, we aimed to provide guidance for designing anti-adhesion materials applied in different soft tissues based on the mechanisms of POA occurrence and development. We first classified the postoperative adhesions into four categories according to the different components of diverse adhesion tissues, and named them as "membranous adhesion", "vascular adhesion", "adhesive adhesion" and "scarred adhesion", respectively. Then, the process of the occurrence and development of POA were analyzed, and the main influencing factors in different stages were clarified. Further, we proposed seven strategies for POA prevention by using biomaterials according to these influencing factors. Meanwhile, the relevant practices were summarized according to the corresponding strategies and the future perspectives were analyzed.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Surgical Sutures and Adhesives · Intestinal and Peritoneal Adhesions · Hemostasis and retained surgical items
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Elucidating the fundamental fibrotic processes driving abdominal adhesion formation10.1038/s41467-020-17883-1 ↗
2. Asherman's syndrome: current perspectives on diagnosis and management10.2147/IJWH.S165474 ↗
3. Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity10.1007/s00595-013-0591-8 ↗
4. Current strategies and future perspectives for intraperitoneal adhesion prevention10.1007/s11605-011-1819-9 ↗
5. Hydrogel adhesion: a supramolecular synergy of chemistry, topology, and mechanics
6. H-bonding supramolecular hydrogels with promising mechanical strength and shape memory properties for postoperative antiadhesion application10.1021/acsami.0c07753 ↗
7. Multifunctional supramolecular hydrogel for prevention of epidural adhesion after laminectomy10.1021/acsnano.0c01658 ↗
8. An injectable peptide hydrogel constructed of natural antimicrobial peptide J-1 and ADP shows anti-infection, hemostasis, and antiadhesion efficacy10.1021/acsnano.1c11206 ↗
9. Use of a supramolecular polymeric hydrogel as an effective post-operative pericardial adhesion barrier10.1038/s41551-019-0442-z ↗
10. Preliminary design of a new degradable medical device to prevent the formation and recurrence of intrauterine adhesions10.1038/s42003-019-0447-x ↗
11. Self-healing hydrogel embodied with macrophage-regulation and responsive-gene-silencing properties for synergistic prevention of peritendinous adhesion10.1002/adma.202106564 ↗
12. Abdominal adhesion prevention: still a sticky subject10.1159/000314805 ↗
13. The inpatient burden of abdominal and gynecological adhesiolysis in the US10.1186/1471-2482-11-13 ↗
14. Adhesion-related readmissions after open and laparoscopic surgery: a retrospective cohort study (SCAR update)10.1016/S0140-6736(19)32636-4 ↗
15. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis10.1016/S0140-6736(13)61687-6 ↗
16. Adhesion barriers for abdominal surgery: a sticky problem10.1016/S0140-6736(13)62002-4 ↗
17. New adhesion formation after laparoscopic and conventional adhesiolysis10.1007/s004640000256 ↗
18. Fouling-resistant zwitterionic polymers for complete prevention of postoperative adhesion10.1073/pnas.2012491117 ↗
19. Biodegradable zwitterionic cream gel for effective prevention of postoperative adhesion
20. Prevention of post-operative adhesions
21. Roy · Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries · 2015 · 25 · 245
22. An injectable and antifouling self-fused supramolecular hydrogel for preventing postoperative and recurrent adhesions10.1016/j.cej.2020.127096 ↗
23. Peritoneal adhesions: occurrence, prevention and experimental models10.1016/j.actbio.2020.08.036 ↗
24. Intra-abdominal adhesions: definition, origin, significance in surgical practice, and treatment options
25. Regulation of ERK1/2 and SMAD2/3 pathways by using multi-layered electrospun PCL-amnion nanofibrous membranes for the prevention of post-surgical tendon adhesion10.2147/IJN.S231538 ↗
26. Clinical outcomes associated with flexor tendon repair10.1016/j.hcl.2004.11.005 ↗
27. Bioresorbable electrospun gelatin/polycaprolactone nanofibrous membrane as a barrier to prevent cardiac postoperative adhesion10.1016/j.actbio.2018.10.022 ↗
28. The society of thoracic surgeons 2008 cardiac surgery risk models: Part 1—coronary artery bypass grafting surgery10.1016/j.athoracsur.2009.05.053 ↗
29. The society of thoracic surgeons 2008 cardiac surgery risk models: Part 2—isolated valve surgery10.1016/j.athoracsur.2009.05.056 ↗
30. Failed back surgery syndrome: diagnostic evaluation10.5435/00124635-200609000-00003 ↗
31. Causes of failure of surgery on the lumbar spine10.1097/00003086-198106000-00032 ↗
32. Spinal cord stimulation and sacral nerve stimulation for postlaminectomy syndrome with significant low back pain10.1111/ner.12144 ↗
33. Safety and efficacy of a novel barrier film to prevent intrauterine adhesion formation after hysteroscopic myomectomy: the PREG1 clinical trial10.1016/j.jmig.2021.07.017 ↗
34. Advances in biomaterials for preventing tissue adhesion10.1016/j.jconrel.2017.06.020 ↗
35. Effect of myomectomy on endometrial cavity: a prospective study of 51 cases10.4103/0974-1208.183509 ↗
36. Role of endometrial suppression on the frequency of intrauterine adhesions after
37. Hysteroscopic treatment of severe Asherman’s syndrome and subsequent fertility10.1093/humrep/14.5.1230 ↗
38. Total adhesions treated by hysteroscopy: must we stop at two procedures?10.1016/j.fertnstert.2012.06.032 ↗
39. Warembourg · Prevention and treatment of intra-uterine synechiae: Review of the literature · 2015 · 44 · 366
40. Reproductive outcome of patients with asherman’s syndrome: a saims experience
41. Uterine synechiae and pregnancy complications10.1097/AOG.0b013e31824be28a ↗
42. Effects of asherman syndrome on maternal and neonatal morbidity with evaluation by conception method10.1016/j.jmig.2020.10.004 ↗
43. A comprehensive review of Asherman’s syndrome: causes, symptoms and treatment options10.1097/GCO.0000000000000378 ↗
44. Combined treatment of xyloglucan derivative hydrogel and anti-C5a receptor antibody in preventing peritoneal adhesion10.1016/j.actbio.2022.08.001 ↗
45. A review: progress in preventing tissue adhesions from a biomaterial perspective10.1039/D0BM02023K ↗
46. Update on biomaterials for prevention of epidural adhesion after lumbar laminectomy10.1016/j.jot.2018.02.001 ↗
47. One-pot construction of cellulose-gelatin supramolecular hydrogels with high strength and pH-responsive properties10.1016/j.carbpol.2018.05.020 ↗
48. A robust, self-healable, and shape memory supramolecular hydrogel by multiple hydrogen bonding interactions10.1002/marc.201800138 ↗
49. Peritoneal repair and post-surgical adhesion formation10.1093/humupd/7.6.547 ↗
50. Electrospun nanofibrous membranes for preventing tendon adhesion10.1021/acsbiomaterials.0c00201 ↗
51. Focus on the primary prevention of intrauterine adhesions
52. The pathology of postcurettage intrauterine adhesions10.1016/0002-9378(66)90452-2 ↗
53. Pathophysiology of adhesions
54. Primordial GATA6 macrophages function as extravascular platelets in sterile injury10.1126/science.abe0595 ↗
55. Larocca · THE LAMINECTOMY MEMBRANE · 1974 · 56 · 545
56. Pathophysiology of adhesion formation and strategies for prevention
57. Biology of the peritoneum in normal homeostasis and after surgical trauma10.1111/j.1463-1318.2007.01345.x ↗
58. Two-way interactions between inflammation and coagulation10.1016/j.tcm.2005.07.004 ↗
59. Perioperative histologic and ultrastructural changes in the pericardium and adhesions10.1016/0003-4975(94)92224-1 ↗
60. The role of fibrinolysis in adhesion formation
61. Peritoneal fibrinolytic activity and intra-abdominal adhesions10.1016/0140-6736(90)91125-T ↗
62. Demonstration of two forms of alpha 2-antiplasmin in plasma by modified crossed immunoelectrophoresis10.1016/0049-3848(84)90033-1 ↗
63. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor10.1016/S0021-9258(18)66755-9 ↗
64. Post-surgical adhesions are triggered by calcium-dependent membrane bridges between mesothelial surfaces10.1038/s41467-020-16893-3 ↗
65. Tsai · Surgical adhesions in mice are derived from mesothelial cells and can be targeted by antibodies against mesothelial markers · 2018 · 10
66. Human peritoneal adhesions are highly cellular, innervated, and vascularized
67. The impact of starch-powdered gloves on the formation of adhesions in rats
68. Fibrin-induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline
69. Tendon healing: repair and regeneration10.1146/annurev-bioeng-071811-150122 ↗
70. Buckman · A physiologic basis for the adhesion-free healing of deperitonealized surfaces · 1976 · 21 · 67
71. The role of hybrid chitosan membranes on scarring process following lumbar surgery: post-laminectomy experimental model10.1179/1743132814Y.0000000414 ↗
72. The effect of 10-hydroxycamptothecine in preventing fibroblast proliferation and epidural scar adhesion after laminectomy in rats10.1016/j.ejphar.2008.07.028 ↗
73. The biology of adhesion formation in the peritoneal cavity10.1053/j.sempedsurg.2014.06.004 ↗
74. A clinical, biological, and biomaterials perspective into tendon injuries and regeneration10.1089/ten.teb.2016.0181 ↗
75. Encircling the tendon repair site with collagen-GAG reduces the Formation of postoperative tendon adhesions in a chicken flexor tendon model10.1016/j.jss.2009.10.010 ↗
76. Mechanisms for pro matrix metalloproteinase activation10.1111/j.1699-0463.1999.tb01524.x ↗
77. Origin and function of myofibroblasts in kidney fibrosis10.1038/nm.3218 ↗
78. Retained surgical swab debris in post-laminectomy arachnoiditis and peridural fibrosis10.1302/0301-620X.70B4.3403620 ↗
79. Biomechanics of tendon injury and repair10.1016/j.jbiomech.2003.11.005 ↗
80. Qi · The renal cortical fibroblast in renal tubulointerstitial fibrosis · 2006 · 38 · 1
81. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study
82. Growth of nerve fibres into murine peritoneal adhesions10.1002/1096-9896(2000)9999:9999<::AID-PATH710>3.0.CO;2-4 ↗
83. Pathogenesis of postoperative adhesion formation10.1002/bjs.7657 ↗
84. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta10.1084/jem.165.1.251 ↗
85. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production10.1073/pnas.84.16.5788 ↗
86. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta110.1083/jcb.142.3.873 ↗
87. Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention10.1089/wound.2012.0393 ↗
88. Myofibroblasts and mechano-regulation of connective tissue remodelling10.1038/nrm809 ↗
89. Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis10.1038/s41419-020-02822-1 ↗
90. Tensile forces drive a reversible fibroblast-to-myofibroblast transition during tissue growth in engineered clefts
91. Wound healing and fibrosis in intestinal disease10.1136/gut.2006.090456 ↗
92. Human peritoneal adhesions show evidence of tissue remodeling and markers of angiogenesis10.1007/s10350-006-0747-3 ↗
93. The small molecule inhibitor QLT-0267 decreases the production of fibrin-induced inflammatory cytokines and prevents post-surgical peritoneal adhesions10.1038/s41598-018-25994-5 ↗
94. Holmdahl · The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair · 1999 · 165 · 1012
95. Role of plasminogen activators during healing after uterine serosal lesioning in the rat10.1016/S0015-0282(02)04569-7 ↗
96. Laurens · Fibrin structure and wound healing · 2006 · 4 · 932
97. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin αMβ2 binding motif10.1172/JCI30134 ↗
98. Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway10.1101/gad.465908 ↗
99. Masamune · Fibrinogen induces cytokine and collagen production in pancreatic stellate cells · 2009 · 58 · 550
100. 2012